Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models

BACKGROUND: With the 2020 target year for elimination of lymphatic filariasis (LF) approaching, there is an urgent need to assess how long mass drug administration (MDA) programs with annual ivermectin + albendazole (IA) or diethylcarbamazine + albendazole (DA) would still have to be continued, and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Stolk, Wilma A, Prada, Joaquin M, Smith, Morgan E, Kontoroupis, Periklis, de Vos, Anneke S, Touloupou, Panayiota, Irvine, Michael A, Brown, Paul, Subramanian, Swaminathan, Kloek, Marielle, Michael, E, Hollingsworth, T Deirdre, de Vlas, Sake J
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Supplement Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5982795/
https://ncbi.nlm.nih.gov/pubmed/29860286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi